Does PALOPEGTERIPARATIDE Cause Hypercalcaemia? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hypercalcaemia have been filed in association with PALOPEGTERIPARATIDE (Yorvipath). This represents 12.2% of all adverse event reports for PALOPEGTERIPARATIDE.
10
Reports of Hypercalcaemia with PALOPEGTERIPARATIDE
12.2%
of all PALOPEGTERIPARATIDE reports
0
Deaths
8
Hospitalizations
How Dangerous Is Hypercalcaemia From PALOPEGTERIPARATIDE?
Of the 10 reports, 8 (80.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Hypercalcaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALOPEGTERIPARATIDE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does PALOPEGTERIPARATIDE Cause?
Nausea (8)
Hypocalcaemia (7)
Blood calcium decreased (6)
Headache (6)
Injection site reaction (6)
Arthralgia (5)
Fatigue (5)
Hypoaesthesia (5)
Paraesthesia (5)
Pruritus (5)
What Other Drugs Cause Hypercalcaemia?
RITUXIMAB (857)
METHOTREXATE (803)
ADALIMUMAB (663)
TOCILIZUMAB (618)
ABATACEPT (612)
ETANERCEPT (602)
DENOSUMAB (599)
ALENDRONATE (594)
INFLIXIMAB (594)
LEFLUNOMIDE (585)